Skip to main content
OpenTrials
Completed

NCT Number: NCT04637880

25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders

Hypothesis:

Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age> 18 years
  • informed consent

Exclusion criteria

  • chronic hypertension
  • kidney disease
  • lupus erythematodes
  • diabetes mellitus
  • malabsorption syndrome
  • hyperparathyroidism
  • surgery on the thyroid gland

Treatment and study plan

Primary outcomes

  1. 25- Hydroxyvitamin D and relation to development of preeclampsia

    Time frame: over course of pregnancy

Secondary outcomes

  1. 25 Hydroxyvitamin D in newborn

    Time frame: once at delivery

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Collaborators

  • Ratiopharm GmbH

Registry information

Acronym: VIDIS

Important dates

Study start
2012
Primary completion
2018
Study completion
2018
First posted
Nov 20, 2020
Registry last updated
Nov 20, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.